Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content

Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content

Patients with multirefractory immune thrombocytopenia (ITP) have limited treatment options. Recent data suggest that specific anti-platelet antibodies may cause destruction of platelets by favoring platelet loss of sialic acid. In this multicenter study 35 patients with ITP, including 16 with multir...

Full description

Bibliographic Details
Main Authors: Nuria Revilla, Javier Corral, Antonia Miñano, Maria Eva Mingot-Castellano, Rosa Maria Campos, Francisco Velasco, Nicolas Gonzalez, Eva Galvez, Ruben Berrueco, Inmaculada Fuentes, Tomas Jose Gonzalez-Lopez, Maria Eugenia de la Morena-Barrio, Jose Ramon Gonzalez-Porras, Vicente Vicente, Maria Luisa Lozano
Format: Article
Language:English
Published: Taylor & Francis Group 2019-08-01
Series:Platelets
Subjects:
anti-gpibα
multirefractory itp
oseltamivir
platelet activation
sialic acid
Online Access:http://dx.doi.org/10.1080/09537104.2018.1513476

Internet

http://dx.doi.org/10.1080/09537104.2018.1513476

Similar Items